Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients

PURPOSE: We aimed to investigate the longitudinal changes in bone metabolic markers and bone mineral density (BMD) after starting or switching from bisphosphonate (BP) to romosozumab (ROMO) or denosumab (DENO) therapies over 12 months and to determine predictors that establish associations with chan...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Tomohiro, Arita, Kosuke, Murota, Eihiro, Hiratsuka, Shigeto, Fujita, Ryo, Ishizu, Hotaka, Asano, Tsuyoshi, Takahashi, Daisuke, Takahata, Masahiko, Iwasaki, Norimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042469/
https://www.ncbi.nlm.nih.gov/pubmed/33847831
http://dx.doi.org/10.1007/s00774-021-01226-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042469/
https://www.ncbi.nlm.nih.gov/pubmed/33847831
http://dx.doi.org/10.1007/s00774-021-01226-1

Ejemplares similares